{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T22:22:27Z","timestamp":1773181347597,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Bozok University Scientific Research Project Units","award":["2014TF-A126"],"award-info":[{"award-number":["2014TF-A126"]}]}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.ijantimicag.2017.01.015","type":"journal-article","created":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T12:31:15Z","timestamp":1490963475000},"page":"595-602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Telbivudine attenuates gentamicin-induced kidney injury in rats"],"prefix":"10.1016","volume":"49","author":[{"given":"Cigdem","family":"Kader","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Sunbul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8634-5752","authenticated-orcid":false,"given":"Yavuz Kursad","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Yarim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulkerim","family":"Bedir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0725-898X","authenticated-orcid":false,"given":"Efe","family":"Karaca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Celikbilek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Resat","family":"Ozaras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0010","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/1469-0691.12220","article-title":"A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match\u2013control study","volume":"20","author":"Tsai","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0015","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/apt.13036","article-title":"Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B","volume":"41","author":"Koklu","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0020","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/j.gastro.2013.11.028","article-title":"Potential benefit of telbivudine on renal function does not outweigh its high rate of antiviral drug resistance and other adverse effects","volume":"146","author":"Yapali","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0025","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/jvh.12362","article-title":"Telbivudine is associated with improvement of renal function in patients transplanted for HBV liver disease","volume":"22","author":"Cholongitas","year":"2015","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0030","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.cgh.2014.11.021","article-title":"Effect of nucleoside and nucleotide analogues on renal function in patients with chronic hepatitis B virus monoinfection","volume":"13","author":"Mallet","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0035","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s10620-014-3486-7","article-title":"Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infection","volume":"60","author":"Buti","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0040","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1007\/s10620-015-3960-x","article-title":"Effectiveness and safety of tenofovir disoproxil fumarate in chronic hepatitis B: a 3-year prospective field practice study in Germany","volume":"61","author":"Petersen","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0045","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/jvh.12217","article-title":"Telbivudine protects renal function in patients with chronic hepatitis B infection in conjunction with adefovir-based combination therapy","volume":"21","author":"Lee","year":"2014","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0050","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1053\/j.gastro.2013.09.031","article-title":"Telbivudine improves renal function in patients with chronic hepatitis B","volume":"146","author":"Gane","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0055","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s12664-013-0325-2","article-title":"Increased eGFR with telbivudine in combination therapy of chronic hepatitis infection","volume":"33","author":"Amarapurkar","year":"2014","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0060","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cmi.2015.05.035","article-title":"Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience","volume":"22","author":"Tsai","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0065","doi-asserted-by":"publisher","first-page":"e2400","DOI":"10.1097\/MD.0000000000002400","article-title":"Risk factors for renal functional decline in chronic hepatitis B patients receiving oral antiviral agents","volume":"95","author":"Shin","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0070","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/1479-5876-12-205","article-title":"Detection of cystatin C biomarker for clinical measurement of renal disease by developed ELISA diagnostic kits","volume":"12","author":"Jiang","year":"2014","journal-title":"J Transl Med"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0075","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.clinbiochem.2006.10.014","article-title":"How to estimate GFR\u2013serum creatinine, serum cystatin C or equations","volume":"40","author":"Herget-Rosenthal","year":"2007","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0080","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0085","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/1470320308098343","article-title":"Experimental models for nephropathy","volume":"9","author":"Balakumar","year":"2008","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0090","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.tox.2010.08.013","article-title":"Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity","volume":"277","author":"Hoffmann","year":"2010","journal-title":"Toxicology"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0095","author":"European Medicines Agency"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0100","first-page":"296","article-title":"Effect of six antiretroviral drugs (delavirdine, stavudine, lamivudine, nelfinavir, amprenavir and lopinavir\/ritonavir in association) on albino pregnant rats (Rattus norvegicus Albinus, Rodentia, Mammalia): biological assay","volume":"79","author":"Nakamura","year":"2014","journal-title":"Ceska Gynekol"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0105","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/ndt\/gfp457","article-title":"Increased urinary losses of carnitine and decreased intramitochondrial coenzyme A in gentamicin-induced acute renal failure in rats","volume":"25","author":"Al-Shabanah","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0110","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","author":"European Association for the Study of the Liver","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0120","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3851\/IMP1496","article-title":"Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy","volume":"15","author":"Lui","year":"2010","journal-title":"Antivir Ther"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0125","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12985-016-0522-6","article-title":"Potential effects of telbivudine and entecavir on renal function: a systematic review and meta-analysis","volume":"13","author":"Wu","year":"2016","journal-title":"Virol J"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2017.01.015_bib0130","first-page":"139","article-title":"Preclinical assessment on renal function and toxicity of chronic hepatitis B (CHB) drugs telbivudine, entecavir, tenofovir and adefovir","volume":"7","author":"Uteng","year":"2013","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0135","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.3109\/00365521.2014.962604","article-title":"Significant renoprotective effect of telbivudine during preemptive antiviral therapy in advanced liver cancer patients receiving cisplatin-based chemotherapy: a case\u2013control study","volume":"49","author":"Lin","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0140","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/apt.12538","article-title":"Review article: nucleos(t)ide analogues in patients with chronic hepatitis B virus infection and chronic kidney disease","volume":"39","author":"Pipili","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0145","doi-asserted-by":"publisher","first-page":"e15074","DOI":"10.5812\/hepatmon.15074","article-title":"Decrease of serum angiotensin converting enzyme levels upon telbivudine treatment for chronic hepatitis B virus infection and negative correlations between the enzyme levels and estimated glomerular filtration rates","volume":"14","author":"Liang","year":"2014","journal-title":"Hepat Mon"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0150","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/jgh.12499","article-title":"Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment","volume":"29","author":"Fung","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ijantimicag.2017.01.015_bib0155","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/596829","article-title":"Hepatitis B virus infection and the kidney: renal abnormalities in HBV patients, antiviral drugs handling, and specific follow-up","author":"Deray","year":"2015","journal-title":"Adv Hepatol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917301024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917301024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T22:53:59Z","timestamp":1535928839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857917301024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0924857917301024"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.01.015","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Telbivudine attenuates gentamicin-induced kidney injury in rats","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}